Stockscreener 앱 받기
6.85
0.44%
-0.03
시간 외 거래:
6.85
전일 마감가:
$6.88
열려 있는:
$6.81
하루 거래량:
591.67K
Relative Volume:
0.98
시가총액:
$832.62M
수익:
$58.49M
순이익/손실:
$-105.04M
주가수익비율:
-5.7772
EPS:
-1.1857
순현금흐름:
$-13.78M
1주 성능:
-4.99%
1개월 성능:
-12.18%
6개월 성능:
-44.89%
1년 성능:
-25.30%
1일 변동 폭
$6.79
$7.20
1주일 범위
$6.68
$7.395
52주 변동 폭
$6.68
$13.77
Immatics N V Stock (IMTX) Company Profile
IMTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
6.85 | 832.62M | 58.49M | -105.04M | -13.78M | -1.2997 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-07 | 개시 | Piper Sandler | Overweight |
| 2023-11-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-03-31 | 개시 | Mizuho | Buy |
| 2023-03-24 | 개시 | Bryan Garnier | Buy |
| 2020-11-20 | 개시 | BofA Securities | Buy |
| 2020-09-22 | 개시 | Goldman | Buy |
| 2020-07-27 | 개시 | SVB Leerink | Outperform |
| 2020-07-24 | 개시 | Jefferies | Buy |
모두보기
Immatics N V 주식(IMTX)의 최신 뉴스
Immatics (NASDAQ:IMTX) Hits New 12-Month LowWhat's Next? - MarketBeat
Immatics (NASDAQ:IMTX) Sees Significant Increase in Short Interest - MarketBeat
(IMTX) Technical Pivots with Risk Controls - Stock Traders Daily
Immatics (NASDAQ:IMTX) Trading Down 4.2%What's Next? - MarketBeat
Immatics Faces Termination of Key Collaboration with Bristol Myers Squibb - TipRanks
Immatics (NASDAQ:IMTX) Shares Bought by Frazier Life Sciences Management L.P. - MarketBeat
Wellington Management Group LLP Has $110.46 Million Stock Holdings in Immatics (NASDAQ:IMTX) - MarketBeat
The Manufacturers Life Insurance Company Grows Stock Position in Immatics (NASDAQ:IMTX) - Defense World
Reviewing bluebird bio (NASDAQ:BLUE) and Immatics (NASDAQ:IMTX) - Defense World
Why Is Immatics N.V. (IMTX) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? - Yahoo Finance
Walleye Capital LLC Lowers Stock Holdings in Immatics (NASDAQ:IMTX) - MarketBeat
Braidwell LP Makes New $18.80 Million Investment in Immatics (NASDAQ:IMTX) - MarketBeat
Immatics NV (FRA:4A3) EBITDA per Share : €-0.40 (TTM As of Sep. 2024) - GuruFocus.com
Vestal Point Capital LP Grows Stock Holdings in Immatics (NASDAQ:IMTX) - MarketBeat
Immatics (NASDAQ:IMTX) Upgraded by The Goldman Sachs Group to "Strong-Buy" Rating - MarketBeat
Exscientia (NASDAQ:EXAI) & Immatics (NASDAQ:IMTX) Head to Head Comparison - Defense World
Immatics N.V. Reports Strong Q3 2024 Progress and Financials - TipRanks
(IMTX) Investment Analysis - Stock Traders Daily
Cantor Fitzgerald Raises Earnings Estimates for Immatics - Defense World
Immatics FY2024 EPS Forecast Boosted by Cantor Fitzgerald - MarketBeat
Analysts Set Expectations for Immatics FY2024 Earnings - Defense World
FY2024 EPS Estimates for Immatics Increased by Analyst - MarketBeat
Immatics (NASDAQ:IMTX) Reaches New 1-Year Low Following Analyst Downgrade - Defense World
Bank of America Has Lowered Expectations for Immatics (NASDAQ:IMTX) Stock Price - Defense World
Immatics N.V. (NASDAQ:IMTX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - Yahoo Finance
10 Best German Stocks To Buy Now - Insider Monkey
Is Immatics N.V. (IMTX) the Best German Stock to Buy Now? - Insider Monkey
Bank of America Issues Pessimistic Forecast for Immatics (NASDAQ:IMTX) Stock Price - MarketBeat
Immatics Sees Revenue Surge Despite R&D Expenses - Yahoo Finance
Immatics: Q3 Earnings Snapshot - Milford Mirror
Immatics NV earnings beat by €0.14, revenue topped estimates - Investing.com UK
What Makes Immatics (IMTX) a New Buy Stock - Yahoo Finance
Immatics N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Immatics reports Q3 EPS (EUR 0.11) vs. (EUR 0.32) last year - TipRanks
Immatics (IMTX) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Immatics announces clinical data on TCER IMA402 targeting PRAME - TipRanks
Immatics sees cash runway into 2H27 - TipRanks
Immatics Announces Third Quarter 2024 Financial Results, - GlobeNewswire
Immatics Reports Early Success in Melanoma Treatment, Plans Phase 3 Trial as Cash Position Tops $699M | IMTX Stock News - StockTitan
T. Rowe Price Investment Management, Inc. Reduces Stake in Immatics NV - GuruFocus.com
Immatics (NASDAQ:IMTX) Reaches New 52-Week LowShould You Sell? - MarketBeat
When the Price of (IMTX) Talks, People Listen - Stock Traders Daily
Immatics N.V. Warrants (IMTXW) SEC Filing Summary - Quartzy
IMTX (Immatics NV) FCF Yield % : -4.41 (As of Nov. 11, 2024) - GuruFocus.com
Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME - 新浪香港
Immatics Unveils Promising TCR-T Therapy Developments - TipRanks
Immatics Announces Multiple Presentations at the 39th - GlobeNewswire
Wellington Management Group LLP Increases Stake in Immatics NV - GuruFocus.com
Immatics N V (IMTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.88%
2.65%
자본화:
|
볼륨(24시간):